{"count":97,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=H.R.+9393&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/2dcf6c95-dd6e-4e00-b52b-3cbba7b19139/","filing_uuid":"2dcf6c95-dd6e-4e00-b52b-3cbba7b19139","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2dcf6c95-dd6e-4e00-b52b-3cbba7b19139/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Alexis D'Amato","dt_posted":"2026-07-10T11:15:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1015 15th St. NW","registrant_address_2":"Ste. 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":400450148,"url":"https://lda.gov/api/v1/registrants/400450148/","house_registrant_id":null,"name":"SMALL BUSINESS MAJORITY FOUNDATION, INC.","description":"Nonprofit organization focused on solving problems faced by America's small businesses.","address_1":"1015 15th St. NW","address_2":"Ste. 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN ARENSMEYER","contact_telephone":"+1 202-609-7336","dt_updated":"2026-10-14T13:53:39.769135-04:00"},"client":{"id":191017,"url":"https://lda.gov/api/v1/clients/191017/","client_id":12,"name":"SMALL BUSINESS MAJORITY FOUNDATION, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-08-10"},"lobbying_activities":[{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Eligibility for Small Business Administration programs (such as 7(a), Microloan, Surety Bond and 504 loan programs), small business development issues, workforce, including immigration policy, and economic impact caused by tariff policies, and healthcare plans for small businesses","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Impacts on small business issues from H.R.1 (OBBBA) including small business tax parity","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Transparency in lending for small business loan products (Small Business Financing Disclosure Act H.R.4192/S.2021 (118th Congress); eligibility requirements impacting legal permanent residents and individuals lawfully in the U.S. for Small Business Administration guaranteed loan products like 7(a), 504, Microloan, and Surety Bond Guarantee programs; policies requiring more transparency into the Merchant Cash Advance (MCA) industry for small business loans","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Small business programs at the Small Business Administration and the Community Development Financial Institution Fund (CDFI Fund), the Minority Business Development Administration, Internal Revenue Service, funding for antitrust enforcement at the Federal Trade Commission, Rural Business Development Program at the US Department of Agriculture","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Enhanced Premium Tax Credits for Affordable Care Act plans; Medicaid cuts; transparency in healthcare Patients Deserve Price Tags Act (S.2355/H.R.5582) and Lower Cost More Transparency Act 2.0 (H.R. 9393), including site-neutral payment reform for Medicare, billing transparency, and hospital consolidation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Small Business Administration Standard Operating Procedure 50 10 8 regarding loan eligibility for immigrants, including legal permanent residents (green card holders), foreign nationals, and those legally present in the U.S. through the Investing in the American Dream Act (S.4411/H.R.8563); Workforce visa reform for temporary asylum seekers; the Dignity Act of 2025 (H.R.4393)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145696,"prefix":null,"prefix_display":null,"first_name":"ALEXIS","nickname":null,"middle_name":null,"last_name":"D'AMATO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154174,"prefix":null,"prefix_display":null,"first_name":"CONNOR","nickname":null,"middle_name":null,"last_name":"COURSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/064c44ca-0353-4fb0-86b7-9067e4957280/","filing_uuid":"064c44ca-0353-4fb0-86b7-9067e4957280","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/064c44ca-0353-4fb0-86b7-9067e4957280/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Diane M. Major","dt_posted":"2026-07-10T17:29:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Ave., NW, Suite 300","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington, DC","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103162,"url":"https://lda.gov/api/v1/registrants/401103162/","house_registrant_id":null,"name":"THE D MAJOR GROUP","description":"Government affairs consulting","address_1":"300 New Jersey Ave., NW, Suite 300","address_2":null,"address_3":null,"address_4":null,"city":"Washington, DC","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DIANE MAJOR","contact_telephone":"+1 202-695-0635","dt_updated":"2026-07-14T14:03:47.385236-04:00"},"client":{"id":198050,"url":"https://lda.gov/api/v1/clients/198050/","client_id":36,"name":"BANNER HEALTH","general_description":"Nonprofit hospital system specializing in integrated health care services.","client_government_entity":false,"client_self_select":false,"state":"AZ","state_display":"Arizona","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-11-13"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Work on hospital payment matters, including Rural Health Transformation funding and Medicaid provider tax provisions as passed under HR 1, the Working Families Tax Cut Act. Also, work on Medicare Advantage and value-based care models, including HR 3467.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Sen. Repub. Policy Com't.","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conf.","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Work on medical research funding, telehealth and extension of advanced premium tax credits. In addition, monitor price reporting proposals including H.R. 9393, the \"Lower Costs, More Transparency Act of 2026.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Senate Republican Policy Comt","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitor implementation of federal health provisions passed earlier under H.R.7148, the \"Consolidated Appropriations Act of FY 2026.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Work on reporting requirements proposed under H.R. 9504, the \"Tax-Exempt Hospital Transparency Act.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Analyst for the Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for the House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/619ea403-f980-4deb-8b81-d349587d4c82/","filing_uuid":"619ea403-f980-4deb-8b81-d349587d4c82","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/619ea403-f980-4deb-8b81-d349587d4c82/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-14T13:17:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":61224,"url":"https://lda.gov/api/v1/clients/61224/","client_id":61224,"name":"UC HEALTH, LLC AND ITS AFFILIATES","general_description":"Healthcare","client_government_entity":null,"client_self_select":false,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-23"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Monitored H1-B visa fees.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored Reinforcing Essential Health Systems for Communities Act (H.R. 7145); Monitored and advised on Medicaid state directed payments; Monitored Medicaid provider taxes; Monitored implementation of H.R. 1, the One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored Consolidated Appropriations Act, 2026 (H.R. 7148); Monitored and advised on FY 2027 Labor, Health and Human Services, and Education Appropriations; Monitored and advised on implementation of H.R. 1, the One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored H.R. 9393, the Lower Costs, More Transparency Act of 2026; Monitored H.R. 9390, the Prices on the Wall Act of 2026; Monitored H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d/","filing_uuid":"c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Donald Horton, Jr.","dt_posted":"2026-07-14T14:58:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"531 South Spring Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Burlington","registrant_state":"NC","registrant_zip":"27215","registrant":{"id":401104793,"url":"https://lda.gov/api/v1/registrants/401104793/","house_registrant_id":null,"name":"LABORATORY CORPORATION OF AMERICA HOLDINGS","description":"Clinical laboratory and drug development services","address_1":"531 South Spring Street","address_2":null,"address_3":null,"address_4":null,"city":"Burlington","state":"NC","state_display":"North Carolina","zip":"27215","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DONALD E. HORTON, JR.","contact_telephone":"+1 336-213-4762","dt_updated":"2026-07-24T14:20:59.309615-04:00"},"client":{"id":202751,"url":"https://lda.gov/api/v1/clients/202751/","client_id":12,"name":"LABORATORY CORPORATION OF AMERICA HOLDINGS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8500, the Timely Access to Coverage Decisions Act, provisions relating to establishment of standards for Medicare local coverage decisions; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; H.R. 9061, the Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act, provisions relating to Medicaid coverage of preeclampsia screening tests; H.R. 8413, the Securing and Establishing Consumer Uniform Rights and Enforcement over Data (SECURE Data) Act, provisions relating to privacy of health care data; A draft of the AI Workforce Assessment and Research (AWARE) Act, provisions relating to disclosure of information on the use and impact of artificial intelligence in employment matters; A draft of the Great American AI Act, provisions relating to regulation of artificial intelligence; Federal policy relating to oversight of laboratory benefit managers; Federal policy relating to access to mandatory code sets for administrative transactions; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67936,"prefix":null,"prefix_display":null,"first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"HORTON","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":67937,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"PREGEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Report language accompanying H.R. 8646, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027, provisions relating to oversight of laboratory-developed tests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67936,"prefix":null,"prefix_display":null,"first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"HORTON","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":67937,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"PREGEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/77c9a8a2-959c-4578-81b3-958fe1dfdb40/","filing_uuid":"77c9a8a2-959c-4578-81b3-958fe1dfdb40","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/77c9a8a2-959c-4578-81b3-958fe1dfdb40/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mary Beth Savary Taylor","dt_posted":"2026-07-15T12:05:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":178485,"url":"https://lda.gov/api/v1/clients/178485/","client_id":113,"name":"AMERICAN HOSPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues involving workforce shortages. Monitored Pandemic and All-Hazards Preparedness and Response Act reauthorization. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to hospitals. Issues related to workplace safety. Issues related to health insurance coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Monitored issues regarding health care workforce proposals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57882,"prefix":"mr","prefix_display":"MR.","first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Issues related to visas for healthcare workers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57882,"prefix":"mr","prefix_display":"MR.","first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 9504, the Tax Exempt Hospital Transparency Act, and isues related to tax exempt hospitals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":"(continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern","new":true},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues involving violence against healthcare employees. H.R. 3178 / S. 1600, Save Healthcare Workers Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57882,"prefix":"mr","prefix_display":"MR.","first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding reimbursement for hospital services. S. 2355 / H.R. 5582, Patients Deserve Price Tags Act. H.R. 9393, Lower Costs, More Transparency Act of 2026. H.R. 9390, Prices on the Wall Act of 2026. Issues concerning Medicaid services. Issues regarding health care sector consolidation. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid and hospitals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cca9f234-482c-4127-b45b-0fc05626bff6/","filing_uuid":"cca9f234-482c-4127-b45b-0fc05626bff6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cca9f234-482c-4127-b45b-0fc05626bff6/print/","filing_document_content_type":"text/html","income":null,"expenses":"85552.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Shari Erickson","dt_posted":"2026-07-15T14:55:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2002,"url":"https://lda.gov/api/v1/registrants/2002/","house_registrant_id":32190,"name":"AMERICAN COLLEGE OF PHYSICIANS","description":null,"address_1":"25 Massachusetts Avenue, NW, Suite 700","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T17:53:37.650943-04:00"},"client":{"id":102673,"url":"https://lda.gov/api/v1/clients/102673/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIANS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPs 2026 Second Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Met with House Doctors Caucus about Medicare payment reform, including draft language to be included in bills for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices. Supported and urged Congress to pass H.R. 8163, the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $54.3 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53637,"prefix":null,"prefix_display":null,"first_name":"SHARI","nickname":null,"middle_name":null,"last_name":"ERICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141127,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PUGACH","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":146685,"prefix":null,"prefix_display":null,"first_name":"VY","nickname":null,"middle_name":null,"last_name":"OXMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3bb90e7a-823a-443d-9ec7-a77f454d7382/","filing_uuid":"3bb90e7a-823a-443d-9ec7-a77f454d7382","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3bb90e7a-823a-443d-9ec7-a77f454d7382/print/","filing_document_content_type":"text/html","income":null,"expenses":"391703.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"George Lyons, Jr.","dt_posted":"2026-07-15T15:21:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":311451,"url":"https://lda.gov/api/v1/registrants/311451/","house_registrant_id":40002,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","description":"Healthcare","address_1":"25 Massachusetts Avenue NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T14:54:36.424626-04:00"},"client":{"id":183820,"url":"https://lda.gov/api/v1/clients/183820/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1999-12-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPs 2026 Second Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Met with House Doctors Caucus about Medicare payment reform, including draft language to be included in bills for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices. Supported and urged Congress to pass H.R. 8163, the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $54.3 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":37837,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60177,"prefix":null,"prefix_display":null,"first_name":"JARED","nickname":null,"middle_name":null,"last_name":"FROST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":40417,"prefix":null,"prefix_display":null,"first_name":"SHUAN","nickname":null,"middle_name":null,"last_name":"TOMLINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":104508,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"LYONS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7c80590e-8829-41cf-a635-db969186403f/","filing_uuid":"7c80590e-8829-41cf-a635-db969186403f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7c80590e-8829-41cf-a635-db969186403f/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-07-16T11:11:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Issues pertaining to prior authorization - HR 3514, Improving Seniors Timely Access to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a86ce826-1f1e-4eb3-b6df-3e1e0c78875b/","filing_uuid":"a86ce826-1f1e-4eb3-b6df-3e1e0c78875b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/a86ce826-1f1e-4eb3-b6df-3e1e0c78875b/print/","filing_document_content_type":"text/html","income":"33750.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Neleen Eisinger","dt_posted":"2026-07-16T15:51:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5826 Highland Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Chevy Chase","registrant_state":"MD","registrant_zip":"20815","registrant":{"id":401018874,"url":"https://lda.gov/api/v1/registrants/401018874/","house_registrant_id":null,"name":"RUBIN HEALTH POLICY CONSULTING, LLC","description":"consulting services","address_1":"5826 Highland Drive","address_2":null,"address_3":null,"address_4":null,"city":"Chevy Chase","state":"MD","state_display":"Maryland","zip":"20815","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NELEEN EISINGER","contact_telephone":"+1 202-253-7296","dt_updated":"2026-07-24T09:55:56.959961-04:00"},"client":{"id":196921,"url":"https://lda.gov/api/v1/clients/196921/","client_id":48,"name":"ASSOCIATION OF AMERICAN MEDICAL COLLEGES","general_description":"Trade association","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored proposals that impact academic medicine access or medical research, including: proposals related to the reauthorization of HRSA Title VII and VIII health care workforce programs including the \"EMPOWER for Health Act (S. 4110)\", the \"Tax Exempt Hospital Transparency Act (H.R. 9504)\", The \"Lower Costs, More Transparency Act (H.R. 9393)\" and the \"Prices on the Wall Act (H.R. 9390)\".","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57952,"prefix":null,"prefix_display":null,"first_name":"NELEEN","nickname":null,"middle_name":null,"last_name":"EISINGER","suffix":null,"suffix_display":null},"covered_position":"Legislative staff","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d01a6950-cb02-41e9-a6a9-031b72c5554a/","filing_uuid":"d01a6950-cb02-41e9-a6a9-031b72c5554a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d01a6950-cb02-41e9-a6a9-031b72c5554a/print/","filing_document_content_type":"text/html","income":"39000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Neleen Eisinger","dt_posted":"2026-07-16T15:55:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5826 Highland Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Chevy Chase","registrant_state":"MD","registrant_zip":"20815","registrant":{"id":401018874,"url":"https://lda.gov/api/v1/registrants/401018874/","house_registrant_id":null,"name":"RUBIN HEALTH POLICY CONSULTING, LLC","description":"consulting services","address_1":"5826 Highland Drive","address_2":null,"address_3":null,"address_4":null,"city":"Chevy Chase","state":"MD","state_display":"Maryland","zip":"20815","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NELEEN EISINGER","contact_telephone":"+1 202-253-7296","dt_updated":"2026-07-24T09:55:56.959961-04:00"},"client":{"id":196920,"url":"https://lda.gov/api/v1/clients/196920/","client_id":24,"name":"KINDRED HEALTHCARE D/B/A SCIONHEALTH (FKA KINDRED HEALTHCARE OPERATING, INC)","general_description":"Healthcare company","client_government_entity":false,"client_self_select":false,"state":"KY","state_display":"Kentucky","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored proposals that impact access to acute and long term acute care hospital services, including: the \"Rural Patient Monitoring Act (H.R. 3108)\", the \"Saving Today's Acute-Care Resources Act (H.R. 9468)\", the \"Lower Costs, More Transparency Act (H.R. 9393)\" and the \"Medicare Advantage Improvement Act (S. 4384/H.R. 8375)\".","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57952,"prefix":null,"prefix_display":null,"first_name":"NELEEN","nickname":null,"middle_name":null,"last_name":"EISINGER","suffix":null,"suffix_display":null},"covered_position":"Legislative Staff","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b76157ae-edb4-43df-b781-370bab69c09f/","filing_uuid":"b76157ae-edb4-43df-b781-370bab69c09f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b76157ae-edb4-43df-b781-370bab69c09f/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-17T09:06:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":167893,"url":"https://lda.gov/api/v1/clients/167893/","client_id":1852,"name":"CATHOLIC HEALTH ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicare, tax issues and all general representation of health issues of concern; Monitored H.R. 9393, the Lower Costs, More Transparency Act of 2026, H.R. 9390, the Prices on the Wall Act of 2026, and H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false},{"lobbyist":{"id":16223,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70188,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"GOODMAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)","new":false},{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Medicare, tax issues affecting hospitals, mental health, Better Care Reconciliation Act, issues related to opioids; Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false},{"lobbyist":{"id":16223,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e9c90b44-515e-40d0-b3e2-6df664ce5806/","filing_uuid":"e9c90b44-515e-40d0-b3e2-6df664ce5806","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e9c90b44-515e-40d0-b3e2-6df664ce5806/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-17T09:07:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":54427,"url":"https://lda.gov/api/v1/clients/54427/","client_id":54427,"name":"MICHIGAN HEALTH & HOSPITAL ASSOCIATION","general_description":"Healthcare","client_government_entity":null,"client_self_select":false,"state":"MI","state_display":"Michigan","country":"US","country_display":"United States of America","ppb_state":"MI","ppb_state_display":"Michigan","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-03"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act and tax-exempt status for nonprofit organizations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored and advised on Medicaid state directed payments and provider taxes, implementation of H.R. 1, the One Big Beautiful Bill Act, and Medicare physician reimbursement issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored Consolidated Appropriations Act, 2026 (H.R. 7148).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored and advised on implementation of Rural Health Transformation Program from H.R. 1, the One Big Beautiful Bill Act, H.R. 9393, the Lower Costs, More Transparency Act of 2026, H.R. 9390, the Prices on the Wall Act of 2026, and H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Monitored H1-B visa fees.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0e93ce25-be22-4185-b9b1-7ec361e7d8e2/","filing_uuid":"0e93ce25-be22-4185-b9b1-7ec361e7d8e2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0e93ce25-be22-4185-b9b1-7ec361e7d8e2/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-17T09:08:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":63287,"url":"https://lda.gov/api/v1/clients/63287/","client_id":63287,"name":"WELLSTAR HEALTH SYSTEM INC.","general_description":"Healthcare","client_government_entity":null,"client_self_select":false,"state":"GA","state_display":"Georgia","country":"US","country_display":"United States of America","ppb_state":"GA","ppb_state_display":"Georgia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-11-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored implementation of H.R. 1, the One Big Beautiful Bill Act; Monitored and advised on No Surprises Act; Monitored H.R. 9393, the Lower Costs, More Transparency Act of 2026; Monitored H.R. 9390, the Prices on the Wall Act of 2026; Monitored H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored and advised on Medicaid state directed payments and provider taxes; Monitored implementation of H.R. 1, the One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored Consolidated Appropriations Act, 2026 (H.R. 7148); Monitored and advised on FY 2027 Labor, Health and Human Services, and Education Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act and tax-exempt status for nonprofit organizations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Monitored H1-B visa fees.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":57185,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"BOZELL","suffix":null,"suffix_display":null},"covered_position":"LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/180ba070-00c0-41f3-8205-d66533820814/","filing_uuid":"180ba070-00c0-41f3-8205-d66533820814","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/180ba070-00c0-41f3-8205-d66533820814/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-17T09:12:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":72485,"url":"https://lda.gov/api/v1/clients/72485/","client_id":72485,"name":"OHIOHEALTH CORPORATION","general_description":"Healthcare services","client_government_entity":null,"client_self_select":false,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored implementation of Medicaid provisions in H.R. 1, the One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored implementation of H.R. 1, the One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored implementation of Rural Health Transformation Program from H.R. 1, the One Big Beautiful Bill Act; Monitored H.R. 9393, the Lower Costs, More Transparency Act of 2026; Monitored H.R. 9390, the Prices on the Wall Act of 2026; Monitored and advised on H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":146689,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PLANNING","suffix":null,"suffix_display":null},"covered_position":"Floor Dir, House Maj Whip; Staff Dir, House Smll Biz Cmte; Spec. Asst to Pres/Leg Affairs, Exec Office of Pres; Dep. Dir Coalitions& Mmbr Services, House Financial Cmte; Floor Asst, House Maj Whip; Spec. Asst, House Chf Dep. Whip; Staff Asst, Speaker","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dee2f7a9-47ca-4dcf-ae12-4e397ab5d099/","filing_uuid":"dee2f7a9-47ca-4dcf-ae12-4e397ab5d099","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/dee2f7a9-47ca-4dcf-ae12-4e397ab5d099/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Joyce E. Gresko","dt_posted":"2026-07-17T13:39:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Ave, NW","registrant_address_2":"Suite 810","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1923,"url":"https://lda.gov/api/v1/registrants/1923/","house_registrant_id":30533,"name":"AMERICAN CLINICAL LABORATORY ASSN","description":"national trade association for clinical laboratories","address_1":"1201 Pennsylvania Ave, NW","address_2":"Suite 810","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HOLLY BRUGGEN","contact_telephone":"+1 202-637-9466","dt_updated":"2026-07-06T14:50:05.069888-04:00"},"client":{"id":102665,"url":"https://lda.gov/api/v1/clients/102665/","client_id":12,"name":"AMERICAN CLINICAL LABORATORY ASSN","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-12-07"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; artificial intelligence in laboratory services; laboratory coding, pricing, coverage, and payment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152749,"prefix":"mrs","prefix_display":"MRS.","first_name":"LAURA","nickname":null,"middle_name":"STEVENS","last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":"Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood","new":false},{"lobbyist":{"id":139358,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"VAN METER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152634,"prefix":"mrs","prefix_display":"MRS.","first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BRUGGEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139358,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"VAN METER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152634,"prefix":"mrs","prefix_display":"MRS.","first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BRUGGEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152749,"prefix":"mrs","prefix_display":"MRS.","first_name":"LAURA","nickname":null,"middle_name":"STEVENS","last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":"Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152634,"prefix":"mrs","prefix_display":"MRS.","first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BRUGGEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152749,"prefix":"mrs","prefix_display":"MRS.","first_name":"LAURA","nickname":null,"middle_name":"STEVENS","last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":"Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152749,"prefix":"mrs","prefix_display":"MRS.","first_name":"LAURA","nickname":null,"middle_name":"STEVENS","last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":"Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood","new":false},{"lobbyist":{"id":152634,"prefix":"mrs","prefix_display":"MRS.","first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BRUGGEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0b0fe086-27fe-4be3-b739-a3202a893cb2/","filing_uuid":"0b0fe086-27fe-4be3-b739-a3202a893cb2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0b0fe086-27fe-4be3-b739-a3202a893cb2/print/","filing_document_content_type":"text/html","income":null,"expenses":"520000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Joshua Thompson","dt_posted":"2026-07-17T15:27:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"10 Hudson Yards","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10001","registrant":{"id":400853510,"url":"https://lda.gov/api/v1/registrants/400853510/","house_registrant_id":null,"name":"GUARDIAN LIFE INSURANCE COMPANY OF AMERICA","description":"Insurance and related financial products and services","address_1":"10 Hudson Yards","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOSHUA THOMPSON","contact_telephone":"+1 212-919-3451","dt_updated":"2026-07-27T12:32:37.062907-04:00"},"client":{"id":195682,"url":"https://lda.gov/api/v1/clients/195682/","client_id":12,"name":"GUARDIAN LIFE INSURANCE COMPANY OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-11-21"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General tax issues related to the business of insurance and insurance products, taxation of life insurer reserves, and deferred acquisition costs; tax treatment of paid sick and family medical leave benefits; ACA advanced premium tax credits. Current law tax exclusion for employer provided benefits. H.R. 2547, S. 1335 - Secure Family Futures Act. ISSUE: Treatment of life insurer held bonds.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55412,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"RENFREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66583,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":"DONOVAN","last_name":"HAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Patient Protection and Affordable Care Act (Implementation). ISSUE: General issues related to dental benefits. Health Care Education Reconciliation Act (Implementation). ISSUE: General issues related to dental benefits. H.R. 1397, S.1164- Increasing Access to Dental Insurance Act H.R. 1521, - DOC Access Act - Issues related to dental and vision insurance. H.R. 9393, Lower Costs, More Transparency Act of 2026; Issue: Vision insurance benefits Advanced Premium Tax Credits","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55412,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"RENFREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"General insurance issues, including issues related to insurance benefits Risk weighting of non-public insurers under potential banking regulations H.R. 3437/S. 1544 - Insurance Data Protection Act. The bill would prohibit the Federal Insurance Office of the Department of the Treasury and other financial regulators from collecting data directly from an insurance company H.R. 643 - Federal Insurance Office Elimination Act; Issues related to the elimination of the FIO office. General education on investment and asset liability matching.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66583,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":"DONOVAN","last_name":"HAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55412,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"RENFREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Customer data protection - to provide customers with federal, uniform national standards on consumer data disclosures and other privacy rights. Status of current litigation and background and status of fiduciary related regulations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66583,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":"DONOVAN","last_name":"HAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"RET","general_issue_code_display":"Retirement","description":"H.R. 1013 - Retirement Fairness for Charities and Educational Institutions Act. ISSUE: parity investing options across retirement plans Lifetime income and alternative assets options in retirement plans","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55412,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"RENFREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"Review of the Federal Home Loan Banking system H.R. 6644 - 21st Century ROAD to Housing Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55412,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"RENFREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66583,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":"DONOVAN","last_name":"HAINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/fe761c58-0637-4199-9062-747a124fa71a/","filing_uuid":"fe761c58-0637-4199-9062-747a124fa71a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/fe761c58-0637-4199-9062-747a124fa71a/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tavarski Hughes","dt_posted":"2026-07-18T18:16:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"240 Madison Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"MEMPHIS","registrant_state":"TN","registrant_zip":"38103","registrant":{"id":6440,"url":"https://lda.gov/api/v1/registrants/6440/","house_registrant_id":33435,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","description":null,"address_1":"240 Madison Avenue","address_2":null,"address_3":null,"address_4":null,"city":"MEMPHIS","state":"TN","state_display":"Tennessee","zip":"38103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAVARSKI HUGHES","contact_telephone":"+1 901-417-2486","dt_updated":"2026-07-18T18:34:35.847553-04:00"},"client":{"id":108763,"url":"https://lda.gov/api/v1/clients/108763/","client_id":12,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Federal Budget Process; Hospital Billing/Consolidation; Maternal Health; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Health Savings Accounts; Suprise Billing; Artificial Intelligence S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes. H.R. 8684 - Transparency in Billing Act of 2026 To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 9393 - Lower Costs, More Transparency Act of 2026 To promote price transparency in the health care sector","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform; Program Fraud Waste and Abuse S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington H.R. 93932 - Medicare Advantage Cost Transparency Act To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data. H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 To amend Title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. H.R. 8871 - DME Scammer Prevention Act of 2026 To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies. S. 3762 - Prior Authorization Relief Act To amend part C of the title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"AHIP","url":"www.ahip.org","address_1":"601 Pennsylvania Avenue, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/ea6dd370-e686-4ae0-bf0f-388ac9c81073/","filing_uuid":"ea6dd370-e686-4ae0-bf0f-388ac9c81073","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ea6dd370-e686-4ae0-bf0f-388ac9c81073/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tom Trent","dt_posted":"2026-07-18T19:24:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1450 Production Road","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Fort Wayne","registrant_state":"IN","registrant_zip":"46808","registrant":{"id":401110056,"url":"https://lda.gov/api/v1/registrants/401110056/","house_registrant_id":77311,"name":"PARKVIEW HEALTH SYSTEM, INC.","description":null,"address_1":"1450 Production Road","address_2":null,"address_3":null,"address_4":null,"city":"Fort Wayne","state":"IN","state_display":"Indiana","zip":"46808","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TOM TRENT","contact_telephone":"+1 260-710-7036","dt_updated":"2026-07-30T17:26:40.141869-04:00"},"client":{"id":70104,"url":"https://lda.gov/api/v1/clients/70104/","client_id":70104,"name":"PARKVIEW HEALTH SYSTEM, INC.","general_description":"Healthcare system.","client_government_entity":null,"client_self_select":true,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-07-22"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General health care issues related to hospitals; Lower costs, More transparency Act (H.R. 9393).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152193,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"TRENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152517,"prefix":null,"prefix_display":null,"first_name":"ELLEN","nickname":null,"middle_name":null,"last_name":"CUTTER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3be680ee-38d4-4aa8-871c-18c0201fadba/","filing_uuid":"3be680ee-38d4-4aa8-871c-18c0201fadba","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3be680ee-38d4-4aa8-871c-18c0201fadba/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mike Nielsen","dt_posted":"2026-07-18T23:41:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1307 New York Ave., NW Suite 600","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":76992,"url":"https://lda.gov/api/v1/registrants/76992/","house_registrant_id":36118,"name":"CGCN GROUP, LLC","description":"Public Affairs Consultants","address_1":"1307 New York Ave., NW Suite 600","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVE CLARK","contact_telephone":"+1 202-628-0028","dt_updated":"2026-07-12T16:09:24.002258-04:00"},"client":{"id":68668,"url":"https://lda.gov/api/v1/clients/68668/","client_id":68668,"name":"PARKVIEW HEALTH SYSTEM, INC.","general_description":"Network healthcare provider","client_government_entity":null,"client_self_select":false,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-09-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General health care issues related to hospitals; Lower Costs, More Transparency Act (H.R. 9393).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142906,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"HAMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154390,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"GILBERT","suffix":null,"suffix_display":null},"covered_position":"(4) Intern, Rep. George Holding, Aug. 2016-Dec 2016; Intern, Sen. Richard Burr, June 2016-July 2016","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/feccdeab-d3ee-452f-a646-58ccb2b6a903/","filing_uuid":"feccdeab-d3ee-452f-a646-58ccb2b6a903","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/feccdeab-d3ee-452f-a646-58ccb2b6a903/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-20T09:08:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":56037,"url":"https://lda.gov/api/v1/clients/56037/","client_id":56037,"name":"JOHNS HOPKINS UNIVERSITY","general_description":"Healthcare and medical research","client_government_entity":null,"client_self_select":false,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-04-11"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored Consolidated Appropriations Act, 2026 (H.R. 7148); Monitored Continuing Appropriations and Extensions Act, 2026; Monitored Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; Monitored and advised on FY 2026 and FY 2027 Appropriations research funding; Monitored and advised on research indirect costs Monitored and advised on FY 2026 and FY 2027 Labor, Health and Human Services, and Education Appropriations; Monitored implementation of H.R. 1, One Big Beautiful Bill Act; Monitored Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025; Advised on High-throughput Materials Discovery For Extreme conditions (HTMDEC) funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Advised and monitored higher education issues; Monitored and advised on medical school nutrition education; Monitored and advised on military education programs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored Medicaid state directed payments and provider taxes; Monitored implementation of H.R. 1, the One Big Beautiful Bill Act; Monitored Medicare physician reimbursement issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored tax-exempt status for nonprofit organizations; Monitored H.R. 9504, the Tax-exempt Hospital Transparency Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Monitored and advised on Artificial Intelligence; Monitored S.854/H.R. 1864 - Risky Research Review Act; Monitored H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; Monitored and advised on H.R. 9102, the Biotech Investment National Security Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Monitored National Defense Authorization Act for FY 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Monitored H1-B visa fees.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advised on U.S. Family Health Plan; Monitored H.R. 9393, the Lower Costs, More Transparency Act of 2026; Monitored H.R. 9390, the Prices on the Wall Act of 2026; Monitored H.R. 6248/S.4027, the Healthy Competition For Better Care Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":134466,"prefix":null,"prefix_display":null,"first_name":"CARLOS","nickname":null,"middle_name":"MIQUEL","last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)","new":false},{"lobbyist":{"id":56118,"prefix":null,"prefix_display":null,"first_name":"TONY","nickname":null,"middle_name":null,"last_name":"ESSALIH","suffix":null,"suffix_display":null},"covered_position":"COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/47e63b7d-e025-43b9-8f2f-e706559f16bb/","filing_uuid":"47e63b7d-e025-43b9-8f2f-e706559f16bb","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/47e63b7d-e025-43b9-8f2f-e706559f16bb/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"John Jurenko","dt_posted":"2026-07-20T10:15:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"525 E. 68th Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10065","registrant":{"id":57098,"url":"https://lda.gov/api/v1/registrants/57098/","house_registrant_id":35230,"name":"THE NEW YORK AND PRESBYTERIAN HOSPITAL","description":"Hospital","address_1":"525 E. 68th Street","address_2":null,"address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10065","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN JURENKO","contact_telephone":"+1 347-920-0848","dt_updated":"2026-07-30T10:46:37.114600-04:00"},"client":{"id":159950,"url":"https://lda.gov/api/v1/clients/159950/","client_id":12,"name":"NEW YORK AND PRESBYTERIAN HOSPITAL","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-08-13"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare program and payments, site-neutral provider payment cuts, Medicaid Disproportionate Share Hospital (DSH) payments, Mobile Stroke Treatment Units and Hospital at Home.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140419,"prefix":null,"prefix_display":null,"first_name":"CARLA","nickname":null,"middle_name":"NICOLE","last_name":"HURT MINTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71365,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"EDWARD","last_name":"JURENKO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 9504 - Tax Exempt Hospital Transparency Act; H.R. 9393 - Lower Cost More Transparency Act; H.R 9390 - Prices on the Wall Act; H.R. 5582, S. 2355 - Patients Deserve Price Tags Act: Provisions related to hospital price transparency and Form 990 reporting. P.L. 119-21: Issues related to the implementation of provisions regarding Essential Plan Cuts, Medicaid financing and eligibility, and other issues impacting hospitals. H.R. 3178; S. 1600 - Save Healthcare Workers Act: Provisions related to protections for health care workers. H.R. 3890 - Resident Physician Shortage Reduction Act: Provisions related to graduate medical education. Issues related to Section 340B drug pricing, healthcare workforce, telehealth, community engagement and health insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140419,"prefix":null,"prefix_display":null,"first_name":"CARLA","nickname":null,"middle_name":"NICOLE","last_name":"HURT MINTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71365,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"EDWARD","last_name":"JURENKO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Issues related to FEMA COVID-19 reimbursement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140419,"prefix":null,"prefix_display":null,"first_name":"CARLA","nickname":null,"middle_name":"NICOLE","last_name":"HURT MINTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71365,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"EDWARD","last_name":"JURENKO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to the Employee Retention Tax Credit.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140419,"prefix":null,"prefix_display":null,"first_name":"CARLA","nickname":null,"middle_name":"NICOLE","last_name":"HURT MINTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"POS","general_issue_code_display":"Postal","description":"Issue with local postmaster.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140419,"prefix":null,"prefix_display":null,"first_name":"CARLA","nickname":null,"middle_name":"NICOLE","last_name":"HURT MINTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/12f60e56-560c-4ab3-92df-8087a77d4428/","filing_uuid":"12f60e56-560c-4ab3-92df-8087a77d4428","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/12f60e56-560c-4ab3-92df-8087a77d4428/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Greg D'Angelo","dt_posted":"2026-07-20T10:30:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":210081,"url":"https://lda.gov/api/v1/clients/210081/","client_id":1005546,"name":"FLORIDA HOSPITAL ASSOCIATION","general_description":"Hospital association.","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to hospitals and the health care workforce. Issues related to health insurance coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52444,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"BADGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51079,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"CHOUDHRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare graduate medical education residency positions. Issues related to Medicaid payments for safety net providers. Issues related to Medicaid disproportionate share hospital payments. Issues related to Medicare reimbursement for hospitals. Issues related to the implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid and hospitals. S. 2355 / H.R. 5582, Patients Deserve Price Tags Act. H.R. 9393, Lower Costs, More Transparency Act of 2026. H.R. 9390, Prices on the Wall Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52444,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"BADGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 9504, the Tax Exempt Hospital Transparency Act and issues related to tax-exempt hospitals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52444,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"BADGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3e6c5f38-2bd0-4493-beea-51efe239e79b/","filing_uuid":"3e6c5f38-2bd0-4493-beea-51efe239e79b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3e6c5f38-2bd0-4493-beea-51efe239e79b/print/","filing_document_content_type":"text/html","income":null,"expenses":"1460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather S. Morris","dt_posted":"2026-07-20T11:35:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1150 CONNECTICUT AVENUE, NW","registrant_address_2":"SUITE 1000","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":306578,"url":"https://lda.gov/api/v1/registrants/306578/","house_registrant_id":38604,"name":"CENTENE CORPORATION","description":null,"address_1":"1150 CONNECTICUT AVENUE, NW","address_2":"SUITE 1000","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER S. MORRIS","contact_telephone":"+1 813-220-2673","dt_updated":"2026-07-30T11:44:37.210826-04:00"},"client":{"id":182010,"url":"https://lda.gov/api/v1/clients/182010/","client_id":12,"name":"CENTENE CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 2355, Patients Deserve Price Tags Act, including provisions related to the hold-harmless of insurers. Issues related to health insurance access and affordability. Issues related to the individual insurance market.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146097,"prefix":null,"prefix_display":null,"first_name":"SIMONE","nickname":null,"middle_name":null,"last_name":"MYRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5454, Medicare Advantage Prompt Pay Act, including provisions related to medical claims payment requirements for Medicare Advantage organizations. H.R. 9393, Lower Costs, More Transparency Act of 2026, including provisions related to the current Transparency in Coverage requirements. Issues related to healthcare quality (Medicare Advantage) and MA Stars policy reform. Issues related to Medicare Advantage supplemental benefits, specifically impact of access to healthy foods on health outcomes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":83810,"prefix":null,"prefix_display":null,"first_name":"DANNY","nickname":null,"middle_name":null,"last_name":"LY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151726,"prefix":null,"prefix_display":null,"first_name":"JACQUELINE","nickname":null,"middle_name":null,"last_name":"BAGGETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/31eede6b-60a7-462a-a4db-1e34d8e1a67e/","filing_uuid":"31eede6b-60a7-462a-a4db-1e34d8e1a67e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/31eede6b-60a7-462a-a4db-1e34d8e1a67e/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Alison Esquea","dt_posted":"2026-07-20T11:54:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th St NW","registrant_address_2":"Ste. 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105208,"url":"https://lda.gov/api/v1/registrants/401105208/","house_registrant_id":null,"name":"CAMBIA HEALTH SOLUTIONS","description":"Innovative health care solutions","address_1":"601 13th St. NW, Ste. 900 South","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISON ESQUEA","contact_telephone":"+1 202-253-5455","dt_updated":"2026-07-27T16:33:38.902734-04:00"},"client":{"id":203401,"url":"https://lda.gov/api/v1/clients/203401/","client_id":12,"name":"CAMBIA HEALTH SOLUTIONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-19"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46), 2026 Proposed NBPP/Individual Market/ACA exchanges; Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, H.R. 6703), PBM Compensation (H.R. 7895), Prescription Drugs (S. 1954, S. 1096, S. 1096, S.1040) Price Transparency (S. 2355, H.R. 9393, H.R. 9397), Prior Authorization (H.R. 9396), 340B.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage: Star Ratings, Risk Adjustment, Supplemental Benefits (H.R. 5746, H.R. 5243), No UPCODE Act (S. 1105), Medicare Prior Authorization and Electronic Prior Authorization (H.R. 3514, H.R. 8375), Provider Directories (S. 891), Telehealth Extending Flexibilities (H.R. 4206, S. 1261), Transparency & PBMs (S. 882; S. 891, S. 3345), Physician Fee Schedule, Site Neutrality (H.R. 7149, H.R. 3417 from 118th), Broker/Agents (H.R. 9395).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1e0353c2-4dee-4a5f-94a1-b8a300ba1f30/","filing_uuid":"1e0353c2-4dee-4a5f-94a1-b8a300ba1f30","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1e0353c2-4dee-4a5f-94a1-b8a300ba1f30/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mary Beth Savary Taylor","dt_posted":"2026-07-20T12:16:00-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":178495,"url":"https://lda.gov/api/v1/clients/178495/","client_id":292,"name":"CLEVELAND CLINIC FOUNDATION","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored Pandemic and All-Hazards Preparedness and Response Act reauthorization. Issues concerning hospitals and the healthcare workforce. Issues involving drug shortages. Issues concerning quantum research. Monitored issues regarding NIH reform. Issues concerning health insurance coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Issues regarding international healthcare workers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57882,"prefix":"mr","prefix_display":"MR.","first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"KENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 9504, the Tax Exempt Hospital Transparency Act and issues related to tax-exempt hospitals. Issues related to OECD Pillar 2 definitions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues concerning Safety from Violence for Healthcare Employees. H.R. 3178 / S.1600, Save Healthcare Workers Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored issues regarding PPS exempt hospitals. Issues concerning reimbursement for hospital services. S. 2355 / H.R. 5582, Patients Deserve Price Tags Act and H.R. 9393, Lower Costs, More Transparency Act of 2026. Issues regarding hospital transparency. Issues regarding healthcare sector consolidation. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid and hospitals. Issues regarding organ transplantation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}